Developing therapies that reprogram tumour-associated macrophages to break the immunosuppressive environment cancers build around themselves.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€3,000,000
Total raised
-
Valuation
6
Employees
-
Founded
Latest round
Pre-seed - October 27, 2025
Pre-seed - €3,000,000
October 27, 2025 · Read the story
✓ verified by our desk
Open roles
Adaptam Therapeutics is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile